Home » Topics » Conferences

Conferences
RSS

GSK-1362885 is safe in healthy volunteers and patients with type 2 diabetes

June 30, 2010

Pilot trial finds XOMA-052 beneficial in uveitis of Behcet's disease

June 29, 2010

Interim phase II data reported on ENB-0040 in childhood hypophosphatasia

June 29, 2010

Pooled phase III data show efficacy of tesamorelin in HIV-related lipodystrophy

June 29, 2010

SB-1518 dose selected for phase II evaluation in myelofibrosis

June 29, 2010

Phase III data released on tanezumab in knee osteoarthritis pain

June 29, 2010

Pardoprunox is effective in PD but dose adjustment is needed

June 28, 2010

Phase III data detailed for add-on safinamide in PD

June 28, 2010

First-in-human data presented on MLN-9708 in nonhematologic cancer

June 28, 2010

RAD-1901 is efficacious in phase IIa trial in postmenopausal women

June 28, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 5, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Study identifies CAND1 as therapeutic target in hepatoblastoma
BioWorld Science
Hepatoblastoma is the most common liver cancer during childhood, with limited therapeutic options in aggressive or relapsed cases. NEDDylation is a...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...